etoposide has been researched along with fosfestrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruoka, M; Miyauchi, T; Nagayama, T; Nishikawa, Y | 1 |
| Ihara, H; Kageyama, S; Kawabe, K; Kurita, Y; Mugiya, S; Nakano, M; Suzuki, K; Ueda, D; Ushiyama, T; Yamaguchi, Y | 1 |
| Azuma, H; Inamoto, T; Katsuoka, Y; Kiyama, S; Kotake, Y; Nishimura, Y; Sakamoto, T; Segawa, N; Takahara, K; Ubai, T | 1 |
1 trial(s) available for etoposide and fosfestrol
| Article | Year |
|---|---|
[Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Orchiectomy; Peplomycin; Prognosis; Prostatic Neoplasms; Survival Rate | 1993 |
2 other study(ies) available for etoposide and fosfestrol
| Article | Year |
|---|---|
[Surgical neoadjuvant chemo-hormonal therapy for advanced prostatic carcinoma].
Topics: Aged; Chemotherapy, Adjuvant; Cystectomy; Diethylstilbestrol; Drug Administration Schedule; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Pelvic Exenteration; Prostatectomy; Prostatic Neoplasms; Urinary Diversion | 1994 |
Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Salvage Therapy; Survival Analysis | 2008 |